HCA Healthcare raises FY25 EPS view to $25.50-$27.00 from $24.05-$25.85

Consensus $25.41. Raises FY25 revenue view to $74B-$76B from $72.8B-$75.8B, consensus $74.74B. Raises FY25 adjusted EBITDA view to $14.7B-$15.3B from $14.3B-$15.1B. Sees FY25 capital expenditures $5B. The company said, “The Company’s guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding volume growth coupled with an anticipated mostly stable operating environment, payer mix, the ongoing impacts of the two major 2024 hurricanes, the impact of current and future health care public policy developments, as well as general business or economic conditions, including inflation, and the impact of trade policies, including tariffs, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets.”